PetVivo Meets Growing Demand for Spryng™ with Appointment of Veterinary Surgeon, Kirsty Husby, as Senior Technical Services Veterinarian
September 09, 2024 10:22 ET
|
PetVivo Holdings, Inc.
Expert Capablites of Senior Vet-Tech to Help Drive Greater Adoption of Spryng as Breakthrough Treatment of Osteoarthritis for Companiaon Animals MINNEAPOLIS, MN, & Annapolis Junction, MD, US,...
PETVIVO HOLDINGS, INC. ANOUNCES LAUNCH OF NEW COMPANY AND PRODUCT WEBSITES
March 07, 2022 07:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, March 07, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative...
PetVivo Reports Second Quarter 2022 Financial Results - Updated
November 15, 2021 17:10 ET
|
PetVivo Holdings, Inc.
Raised approximately 11.25 million in connection with Initial Public Offering Rebranded Kush™ as Spryng™ and commenced sales of Spryng™ Conference call begins at 4:00 p.m. Central time today EDINA,...
PetVivo Holdings Announces Closing of Public Offering and Nasdaq Listing
August 13, 2021 14:47 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, Aug. 13, 2021 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV, PETVW) (“PetVivo” or the “Company”), an emerging biomedical device company focused on the licensing and...
PetVivo Holdings Announces Pricing of Public Offering and Nasdaq Listing
August 10, 2021 20:32 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, Aug. 10, 2021 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV, PETVW) (“PetVivo” or the “Company”), an emerging biomedical device company focused on the licensing and...